DGX Stock: Price, Earnings History and SEC Filings
Quest Diagnostics Incorporated (DGX) last traded at $251.82, down 0.43% on the latest session and up 8.0% over the past month. In its most recent reported quarter (Sep 2026) earnings per share were $3.00 against an analyst estimate of $2.85, a beat of 5.3%.
$251.82 -0.43%
1 month+8.04%
52-week high$256.99
52-week low$171.18
Volume915,571
ExchangeNYSE
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
DGX earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Sep 2026 | Oct 22, 2026 | $3.00 | $2.85 | +5.26% |
| Jun 2026 | Jul 23, 2026 | $3.12 | $2.81 | +11.03% |
| Mar 2026 | Apr 21, 2026 | $2.50 | $2.37 | +5.49% |
| Dec 2025 | Feb 10, 2026 | $2.42 | $2.35 | +2.98% |
DGX beat the analyst EPS estimate in 4 of its last 4 reported quarters. Source: Nasdaq.
Latest SEC filings for DGX
SEC filing data is not available right now. You can search for DGX on SEC EDGAR.
DGX news
- EBay Leads Five Stocks Near Buy Points From Resilient SectorsOct 31, 2026 · finance.yahoo.com
- Quest Diagnostics IncOct 31, 2026 · 247wallst.com
- Labcorp, Quest urge RESULTS Act passage as lab payment cuts loomOct 30, 2026 · medtechdive.com
- Global Genetic Counseling Services Market Report 2026 | Capitalize on AI and Telehealth as Market Hits $4.67 Billion by 2030: Labcorp, Quest Diagnostics, Natera, GeneDxOct 30, 2026 · finance.yahoo.com
- Global Fetal Aneuploidy Confirmation Testing Market Report 2026 | Capitalize on 10.6% CAGR to $2.36 Billion by 2030 with Thermo Fisher, Labcorp, Quest Diagnostics and IlluminaOct 30, 2026 · finance.yahoo.com
- Can Hims & Hers Stock Fall 30%?Oct 28, 2026 · trefis.com
- Will DaVita's Q3 Earnings Reflect Improving Treatment Growth Trends?Oct 27, 2026 · finance.yahoo.com
- Hasbro Upgraded, General Motors Downgraded: Updated Rankings on Top Blue-Chip StocksOct 26, 2026 · finance.yahoo.com
About Quest Diagnostics Incorporated
Quest Diagnostics Incorporated (DGX) is a US-listed public company on NYSE.